Zevra Therapeutics (ZVRA) Shares Issued (2016 - 2025)
Historic Shares Issued for Zevra Therapeutics (ZVRA) over the last 8 years, with Q3 2025 value amounting to $3.0 million.
- Zevra Therapeutics' Shares Issued fell 9525.01% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 9153.87%. This contributed to the annual value of $64.5 million for FY2024, which is 95660.01% up from last year.
- As of Q3 2025, Zevra Therapeutics' Shares Issued stood at $3.0 million, which was down 9525.01% from $968000.0 recorded in Q2 2025.
- Zevra Therapeutics' Shares Issued's 5-year high stood at $63.4 million during Q3 2024, with a 5-year trough of -$2.3 million in Q3 2021.
- For the 5-year period, Zevra Therapeutics' Shares Issued averaged around $7.7 million, with its median value being $968000.0 (2025).
- Over the last 5 years, Zevra Therapeutics' Shares Issued had its largest YoY gain of 11946603.77% in 2024, and its largest YoY loss of 14277.11% in 2024.
- Zevra Therapeutics' Shares Issued (Quarter) stood at -$2.3 million in 2021, then surged by 104.6% to $108000.0 in 2022, then soared by 5350.93% to $5.9 million in 2023, then soared by 976.44% to $63.4 million in 2024, then tumbled by 95.25% to $3.0 million in 2025.
- Its Shares Issued stands at $3.0 million for Q3 2025, versus $968000.0 for Q2 2025 and $2.0 million for Q1 2025.